0.8673

2.19% -0.0194

Vor Biopharma Inc (VOR)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$0.8867

Offen:

$0.87

24-Stunden-Volumen:

232.19K

Relative Volume:

0.41

Marktkapitalisierung:

$59.56M

Einnahmen:

Nettoeinkommen (Verlust:

$-112.46M

KGV:

-0.4272

EPS:

-2.03

Netto-Cashflow:

$-99.89M

1W Leistung:

-12.50%

1M Leistung:

+9.12%

6M Leistung:

-27.73%

1J Leistung:

-62.13%

1-Tages-Spanne:

$0.8443

$0.8817

1-Wochen-Bereich:

$0.8301

$1.03

52-Wochen-Spanne:

$0.63

$3.1399

Vor Biopharma Inc Stock (VOR) Company Profile

Firmenname

Vor Biopharma Inc

Sektor

Healthcare (1176)

Branche

Biotechnology (673)

Telefon

617-655-6580

Adresse

100 CAMBRIDGEPARK DRIVE, CAMBRIDGE

Mitarbeiter

168

Twitter

Nächster Verdiensttermin

2024-11-05

Neueste SEC-Einreichungen

VOR's Discussions on Twitter

Vergleichen Sie VOR mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VOR Vor Biopharma Inc	0.8673	59.56M	0	-112.46M	-99.89M	-1.64
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-07-26	Eingeleitet	Wedbush	Outperform
2022-04-27	Eingeleitet	Goldman	Neutral
2021-12-17	Eingeleitet	H.C. Wainwright	Buy
2021-12-03	Eingeleitet	Robert W. Baird	Outperform
2021-12-02	Eingeleitet	Oppenheimer	Outperform
2021-10-19	Eingeleitet	JMP Securities	Mkt Outperform
2021-03-25	Eingeleitet	B. Riley Securities	Buy
2021-03-03	Eingeleitet	Barclays	Overweight
2021-03-03	Eingeleitet	Evercore ISI	Outperform
2021-03-02	Eingeleitet	Goldman	Sell
2021-03-02	Eingeleitet	Stifel	Buy

Alle ansehen

Vor Biopharma Inc Aktie (VOR) Neueste Nachrichten

Dec 17, 2024

Vor Biopharma Inc. (NYSE:VOR) Given Consensus Recommendation of “Buy” by Analysts - Defense World

Dec 17, 2024

Vor Biopharma Inc. (NYSE:VOR) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Dec 17, 2024

Dec 14, 2024

Vor Biopharma's SWOT analysis: stock shows promise amid AML treatment advances - Investing.com Canada

Dec 14, 2024

Dec 13, 2024

Vor Biopharma’s (VOR) Buy Rating Reiterated at HC Wainwright - Defense World

Dec 13, 2024

Dec 10, 2024

Vor Biopharma’s (VOR) “Outperform” Rating Reaffirmed at Wedbush - Defense World

Dec 10, 2024

Vor Biopharma Announces Updated Clinical Data and FDA Feedback – - Defense World

Dec 10, 2024

Dec 09, 2024

Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from Fda Regarding Registrational Trial Design - Marketscreener.com

Dec 09, 2024

Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design - Marketscreener.com

Dec 09, 2024

Dec 08, 2024

Vor Biopharma : A CD33 Deleted Allograft (Trem cel) Enables Post Hematopoietic Cell Transplant (HCT) Maintenance Dosing of Gemtuzumab Ozogamicin (GO) with Therapeutic Levels of Drug Exposure and Low Hematologic and Hepatic Toxicity in Patients - Marketscreener.com

Dec 08, 2024

Dec 07, 2024

Vor Biopharma : Multimodal atlas of paired diagnosis and relapse AML reveals surface antigens for multi-specific immunotherapy - Marketscreener.com

Dec 07, 2024

Nov 26, 2024

Omeros Corp (OMER) Stock Surges Amidst Biotech Sector Activity - GuruFocus.com

Nov 26, 2024

Nov 22, 2024

Vor Biopharma Inc. (NYSE:VOR) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Nov 22, 2024

Stock Traders Purchase High Volume of Archer Aviation Call Options (NYSE:ACHR) - Defense World

Nov 22, 2024

Navigator Holdings Ltd. (NYSE:NVGS) Given Consensus Rating of “Buy” by Brokerages - Defense World

Nov 22, 2024

Astrana Health, Inc. (NASDAQ:ASTH) Receives Consensus Rating of “Buy” from Analysts - Defense World

Nov 22, 2024

Vor Biopharma Inc. (NYSE:VOR) Given Consensus Rating of “Buy” by Analysts - Defense World

Nov 22, 2024

Kosmos Energy Ltd. (NYSE:KOS) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Nov 22, 2024

Annovis Bio, Inc. (NYSE:ANVS) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Nov 22, 2024

Nov 14, 2024

VOR Biopharma's SWOT analysis: stock shows promise amid clinical progress - Investing.com Nigeria

Nov 14, 2024

Nov 12, 2024

Vor Bio to Participate in the Stifel 2024 Healthcare Conference - GlobeNewswire

Nov 12, 2024

Vor Bio to Present at Stifel Healthcare Conference, Host Key Investor Meetings | VOR Stock News - StockTitan

Nov 12, 2024

Robert W. Baird Lowers Vor Biopharma (NYSE:VOR) Price Target to $14.00 - Defense World

Nov 12, 2024

Vor Biopharma (NYSE:VOR) Given “Buy” Rating at HC Wainwright - Defense World

Nov 12, 2024

Vor Biopharma’s (VOR) “Outperform” Rating Reiterated at Wedbush - Defense World

Nov 12, 2024

Nov 09, 2024

Vor Biopharma (NYSE:VOR) Receives Outperform Rating from Wedbush - MarketBeat

Nov 09, 2024

Nov 08, 2024

Vor Biopharma (NYSE:VOR) Earns Buy Rating from HC Wainwright - MarketBeat

Nov 08, 2024

Vor Biopharma (NYSE:VOR) Price Target Lowered to $14.00 at Robert W. Baird - MarketBeat

Nov 08, 2024

Vor Biopharma Reports Q3 2024 Financial Results - TipRanks

Nov 08, 2024

Nov 07, 2024

Vor Biopharma : Bio Corporate Presentation November 2024 - Marketscreener.com

Nov 07, 2024